Received Jul 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | NG9E2 | IM |
expired dose administered; This non-serious case was reported by a other health professional and described the occurrence of expired vaccine used in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number NG9E2, expiry date 30-JUN-2025) for prophylaxis. On 09-JUL-2025, the patient received Menveo (intramuscular) .5 ml. On 09-JUL-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: expired dose administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 09-JUL-2025 The reporter reported that the patient received expired dose of Menveo which led to, expired vaccine used.